Jazz Pharmaceuticals, Inc. Share Price
NASDAQ: JAZZHealthcare
Live Jazz Pharmaceuticals, Inc. Share Price Chart
O H L
Jazz Pharmaceuticals, Inc. Performance Overview
Days Range
▼
$241.32Low
$244.43High
Markets Today
| Previous Close | $243.84 |
|---|---|
| Open | $244.43 |
| Volume | 97,155 |
| Day's Range | $241.32 - $244.43 |
| 52W Range | $125.78 - $266.38 |
| Market Cap | $15.81 B |
Historical Performance
| 1M Returns | -3.65 |
|---|---|
| 3M Returns | +8.54 |
| 6M Returns | +35.13 |
| 1Y Returns | +85.87 |
| 5Y Returns | +83.04 |
| 10Y Returns | +93.25 |
Jazz Pharmaceuticals, Inc. Fundamentals
| Market Cap | $15.81 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 16.66 |
| PEG Ratio | N/A |
| Revenue | $4.27 B |
| ROE TTM | -0.09 |
| EPS TTM | $14.63 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.29 |
| EBITDA | $1.21 B |
| Profit Margin | -8.35 |
| Market Cap | $15.81 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 16.66 |
| PEG Ratio | N/A |
| Revenue | $4.27 B |
| ROE TTM | -0.09 |
| EPS TTM | $14.63 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.29 |
| EBITDA | $1.21 B |
| Profit Margin | -8.35 |
Jazz Pharmaceuticals, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $897.80 M | $1.05 B | $1.13 B | $1.20 B | $1.07 B | $1.21 B |
| Gross Profit + | $793.20 M | $929.40 M | $997.23 M | $1.04 B | $934.80 M | $1.09 B |
| Operating Income | -$55.90 M | -$686.40 M | $57.51 M | $254.53 M | $213.80 M | $248.20 M |
| EBITDA | $108.90 M | $393.00 M | $278.25 M | $433.70 M | $395.20 M | $504.30 M |
| Interest Expense | -$53.70 M | -$47.40 M | $0 | $0 | -$39.90 M | -$37.10 M |
| Depreciation | $164.80 M | $1.08 B | $220.75 M | $179.17 M | $181.40 M | $256.10 M |
| Income Before Tax | -$109.80 M | -$735.70 M | $9.04 M | $208.47 M | $299.20 M | $210.90 M |
| Income Tax Expense | -$17.80 M | -$17.20 M | -$242.42 M | $4.96 M | $6.10 M | $18.10 M |
| Net Income + | -$92.50 M | -$718.50 M | $251.41 M | $203.45 M | $293.10 M | $192.80 M |
| Net Profit Margin | -10.3% | -68.71% | 22.33% | 16.98% | 27.42% | 15.96% |
Jazz Pharmaceuticals, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $61.00 K | $6.00 K | $6.00 K | $0 | $0 | $0 |
| Reserve & Surplus | $249.20 M | -$294.45 M | -$127.17 M | $77.50 M | $288.20 M | $469.50 M |
| Non-Current Liabilities | $6.14 B | $5.17 B | $5.12 B | $5.10 B | $5.08 B | $4.05 B |
| Current Liabilities | $1.22 B | $2.07 B | $2.27 B | $2.24 B | $2.25 B | $2.23 B |
| Total Liabilities | $7.36 B | $7.24 B | $7.40 B | $7.34 B | $7.33 B | $6.28 B |
| Fixed Assets | $4.90 B | $4.95 B | $4.75 B | $4.63 B | $4.41 B | $4.24 B |
| Current Assets | $4.13 B | $3.35 B | $3.76 B | $4.17 B | $4.58 B | $3.97 B |
| Total Assets | $11.53 B | $10.94 B | $11.36 B | $11.66 B | $11.86 B | $11.08 B |
Jazz Pharmaceuticals, Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$92.50 M | -$718.50 M | $251.41 M | $203.45 M | $293.10 M | $192.80 M |
| Operating Cash Flow | $429.80 M | $88.80 M | $474.62 M | $362.52 M | $408.20 M | $415.70 M |
| Investing Cash Flow | -$169.00 M | -$641.00 M | -$327.80 M | -$329.66 M | $123.10 M | $354.90 M |
| Financing Cash Flow | -$813.50 M | -$124.40 M | -$10.83 M | $32.94 M | -$78.50 M | -$994.50 M |
| Change in Cash | -$551.00 M | -$672.00 M | $136.19 M | $65.83 M | $452.40 M | -$224.50 M |
Jazz Pharmaceuticals, Inc. Peer Comparison
| Company | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|
 | $11.10B | 621.00% | 0.00 | -28.69% | 0.00% |
Jazz Pharmaceuticals, Inc. Return Calculator
The Jazz Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$18,123
Invested Amount$10,000
Est. Returns$8,123
About Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
Popular Stocks
FAQs
What is the share price of Jazz Pharmaceuticals, Inc. today?
Jazz Pharmaceuticals, Inc. (JAZZ) share price as of September 18, 2026 is $241.43. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Jazz Pharmaceuticals, Inc.?
Yes, Indian Investors can invest in the Jazz Pharmaceuticals, Inc. (JAZZ) Share by opening an international trading account with Angel One.
How can I purchase Jazz Pharmaceuticals, Inc. shares in India?
Purchasing Jazz Pharmaceuticals, Inc. (JAZZ) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Jazz Pharmaceuticals, Inc. (JAZZ) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Jazz Pharmaceuticals, Inc.?
Yes, you can purchase fractional shares of Jazz Pharmaceuticals, Inc. (JAZZ) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Jazz Pharmaceuticals, Inc.?
The market capitalization of Jazz Pharmaceuticals, Inc. on September 18, 2026, is $15.81 B.
In which sector Jazz Pharmaceuticals, Inc. belongs?
Jazz Pharmaceuticals, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Jazz Pharmaceuticals, Inc. stocks?
In order to invest in Jazz Pharmaceuticals, Inc. (JAZZ) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
